Home

Presentation

Genetics and Toxicology in Cancer Chemotherapy and Forensic Sciences

My research is focused on finding predictive markers and understanding how pharmaceutiacls and drugs yield desired and undesired effects in humans.

Everyone is different and everyone reacts differently to drugs. Our research group studies how genetic variation affects the effect and risk of side effects in cancer treatment. We also work with new psychoactive drugs (internet drugs), their toxicology and pharmacology. Our third track is genetics in a forensic perspective.

Publications Show/Hide content

2022

News Show/Hide content

white phentanyl powder in small bag.

Research to combat designer drugs

Researchers are involved in the campaign to make designer drugs illegal as quickly as possible. Henrik Gréen investigates how new psychoactive substances act, and why some designer drugs are more lethal than others.
Henrik Green and Niclas Björn in the lab.

Predicting the risk of severe side effects of cancer treatment

Some patients experience life-threatening side effects during cancer treatment. Researchers at LiU have developed a model that can predict which patients have a high probability of side effects.

x

"It's a bit like playing Russian roulette"

As soon as a new online drug appears on the market, a race against the clock starts. Researchers collaborate to as soon as possible determine how the substance affects the body and how dangerous it is.

Research Show/Hide content

Publications Show/Hide content

Latest publications

2022

About me Show/Hide content

CV

Currently: 

  • Research strategist / Molecular Biologist in Engineering and Genomics. Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linköping. 
  • Associate Professor at Division of Drug Research, Department of Medical and Health Sciences, Faculty of Medical Sciences, Linköping University. 

  • 2011--2012. Post-doc at Science for Life Laboratory, Division of Gene technology, Institution for Biotechnology, KTH - Royal Institute of Technology. 
  • 2007 - 2012. Assistant Professor at the Division of Drug Research, Linköping University, Linköping Sweden.
 

Education

  • 2000 - Master of Science in Engineering Biology. Institute of Technology, Linköping University, Linköping, Sweden.    
  • 2007 - PhD in Clinical Pharmacology. Division of Clinical Pharmacology, Department of medicine and Care, Faculty of Health Sciences, Linköping University, Linköping, Sweden. 
  • 2012 - Associate Professor in Pharmacogenetics at Linköping University.

Co-workers Show/Hide content

Organisation Show/Hide content

Tags Show/Hide content